Rachael E. Sapp, ARNP

Rachael Sapp practices at Family First Wellness Clinic in Madison, Florida.

Rachael Sapp's NPI, 1730127044, was assigned on June 2, 2006. Rachael Sapp holds Florida license ARNP1661182.

Rachael Sapp's primary practice is Family First Wellness Clinic, at 486 Sw Rutledge St, Madison, FL 32340-1978. The practice phone is (850) 973-8851.

Rachael Sapp's primary practice is Family First Wellness Clinic in Madison, Florida. Rachael Sapp is also affiliated with Madison County Memorial Hospital. The medical group on file is Family First Wellness Clinic. Dmand AI also links Rachael Sapp to 1 more hospital, 1 group practice or clinic, 1 home health agency, 1 skilled nursing facility and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Rachael Sapp practices, 6 sites in all. Vendor and product names are available with a free account.

Family is Rachael Sapp's primary specialty in the NPI Registry, under taxonomy code 363LF0000X. Rachael Sapp is licensed in Florida.

Dmand AI lists acute sinusitis, acute skin infection, alzheimer's disease, anxiety, arthritis, asthma, bipolar disorder and bladder disease among the conditions Rachael Sapp treats.

CMS data shows 3,410 Medicare services from Rachael Sapp across 16 procedure codes in 2024, for 472 Medicare patients. Medicare paid $133,307 for them. Every service was in an office.

CMS counts 472 Medicare patients who saw Rachael Sapp in 2024. The largest group is 75 to 84, with 187 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 43% are also on Medicaid. Their average risk score is 2.14, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Rachael Sapp's median patient age at 70, with 59% women.

In 2024, Rachael Sapp wrote 23,094 Medicare Part D claims for 759 patients. 84% of them were for generic drugs. CMS names the drug for 22,085 of them, across 243 drugs with 11 or more claims each, at $1,599,362 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Rachael Sapp for performance year 2024, reported as part of a group. Rachael Sapp accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Rachael Sapp as offering telehealth.

CMS Open Payments shows 30 general payments to Rachael Sapp from 13 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $103.